Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28886958 | 0.96 | CYP3A4 (0.58) | LMNADGKACYP3A4TSHRATM | |
| SCHEMBL21571461 | 0.93 | LMNA (0.53) | LMNADGKACYP3A4TSHRATM | |
| SCHEMBL28560061 | 0.93 | MAPT (0.50) | LMNADGKACYP3A4TSHRATM | |
| SCHEMBL28127070 | 0.93 | MAPT (0.50) | LMNADGKACYP3A4TSHRATM | |
| SCHEMBL21571462 | 0.93 | LMNA (0.53) | LMNADGKACYP3A4TSHRATM | |
| SCHEMBL8984419 | 0.91 | MAPT (0.49) | LMNADGKACYP3A4TSHRATM | |
| SCHEMBL27747277 | 0.89 | CYP3A4 (0.51) | LMNADGKACYP3A4TSHRATM | |
| SCHEMBL25438173 | 0.87 | DGKA (0.67) | LMNADGKATSHRTDP1MAPT | |
| SCHEMBL21647233 | 0.87 | DGKA (0.67) | LMNADGKATSHRTDP1MAPT | |
| SCHEMBL20529845 | 0.87 | DGKA (0.67) | LMNADGKATSHRTDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024096480-A1 | SOLID COSMETIC COMPOSITION CONTAINING LARGE AMOUNT OF HYALURONIC ACID | 코스맥스 주식회사 | 2024-05-10 | — | — | WO | claimed |
| WO-2007132971-A1 | WATER-IN-OIL TYPE EMULSION LIQUID ROUGE COMPOSITION | AMOREPACIFIC CORPORATION (KR) | 2007-11-22 | — | — | WO | claimed |
| US-6589519-B1 | Smoothness, softness; shampoo | L'OREAL S.A. (FR) | 2003-07-08 | — | — | US | claimed |
| EP-1009366-B1 | COSMETIC COMPOSITIONS COMPRISING A POLYOXYALKYLATED AMINATED SILICONE BLOCK POLYMER AND A CONDITIONING AGENT AND THEIR USE | OREAL (FR) | 2003-03-26 | — | — | EP | claimed |
| US-5863546-A | CREAM, LOTION, SHAMPOO, CLEANSERS OR POWDER MAKEUP | SWINEHART JAMES M (US) | 1999-01-26 | — | — | US | claimed |
| WO-2024096480-A1 | SOLID COSMETIC COMPOSITION CONTAINING LARGE AMOUNT OF HYALURONIC ACID | 코스맥스 주식회사 | 2024-05-10 | — | — | WO | disclosed |
| EP-3197937-B1 | SILICONE COMPOUNDS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF AMINO ACID BASED SUBSTRATES | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2024-04-24 | — | — | EP | disclosed |
| CN-116138562-A | Stick-shaped cosmetic and preparation method thereof | 克罗莫维斯股份公司 | 2023-05-23 | — | — | CN | disclosed |
| US-10702454-B2 | Solid cosmetic composition in pressed powder form | L'OREAL (FR) | 2020-07-07 | — | — | US | disclosed |
| EP-2928448-B1 | SOLID COSMETIC COMPOSITION IN PRESSED POWDER FORM | OREAL (FR) | 2019-08-21 | — | — | EP | disclosed |
| US-10266656-B2 | Silicone compounds and compositions thereof for the treatment of amino acid based substrates | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2019-04-23 | — | — | US | disclosed |
| US-20170291994-A1 | Silicone Compounds And Compositions Thereof For The Treatment Of Amino Acid Based Substrates | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2017-10-12 | — | — | US | disclosed |
| US-20040131572-A1 | Composition for treating keratinous materials comprising a cationic poly(alkyl) vinyllactam polymer and a protecting or conditioning agent | L'OREAL (FR) | 2004-07-08 | — | — | US | disclosed |
| US-20040037796-A1 | Composition for treating keratinous materials comprising a cationic associative polyurethane polymer and a protecting or conditioning agent | L'OREAL S.A. (FR) | 2004-02-26 | — | — | US | disclosed |
| US-20030157049-A1 | Cosmetic compositions containing a particular aminosilicone and a conditioner, and uses thereof | L'OREAL S.A. (FR) | 2003-08-21 | — | — | US | disclosed |
| US-20030147842-A1 | Cosmetic compositions containing a particular aminosilicone and a conditioner, and uses thereof | L'OREAL S.A. (FR) | 2003-08-07 | — | — | US | disclosed |
| US-6589519-B1 | Smoothness, softness; shampoo | L'OREAL S.A. (FR) | 2003-07-08 | — | — | US | disclosed |
| US-5928652-A | BINDER HAVING ESTER AND FATTY SUBSTANCE | L'OREAL (FR) | 1999-07-27 | — | — | US | disclosed |
| US-5468401-A | Carrier-free metalworking lubricant and method of making and using same | CHEM-TREND, INCORPORATED (US) | 1995-11-21 | — | — | US | disclosed |
| EP-0590959-A2 | Carrier-free metalworking lubricant and method of making and using same | CASTROL LIMITED (GB) | 1994-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030147842-A1 | Cosmetic compositions containing a particular aminosilicone and a conditioner, and uses thereof | CUTA, KRT18, PRMT8 | LMNA 1292/4885DGKA 1452/4885CYP3A4 3398/4885 |
| US-20030157049-A1 | Cosmetic compositions containing a particular aminosilicone and a conditioner, and uses thereof | CUTA, KRT18, MARK1 | LMNA 1368/4885DGKA 1155/4885CYP3A4 4316/4885 |
| US-20040131572-A1 | Composition for treating keratinous materials comprising a cationic poly(alkyl) vinyllactam polymer and a protecting or conditioning agent | KRT18, CUTA, VCL | LMNA 445/4885DGKA 677/4885CYP3A4 4818/4885 |
| US-20040037796-A1 | Composition for treating keratinous materials comprising a cationic associative polyurethane polymer and a protecting or conditioning agent | KRT18, PUF60, FSCN1 | LMNA 1732/4885DGKA 1741/4885CYP3A4 4868/4885 |
| US-10266656-B2 | Silicone compounds and compositions thereof for the treatment of amino acid based substrates | BCAT2, CUTA, BCAT1 | LMNA 1260/4885DGKA 2902/4885CYP3A4 2195/4885 |
| US-10702454-B2 | Solid cosmetic composition in pressed powder form | CUTA, PLIN5, AUP1 | LMNA 945/4885DGKA 2608/4885CYP3A4 4499/4885 |
| US-20170291994-A1 | Silicone Compounds And Compositions Thereof For The Treatment Of Amino Acid Based Substrates | BCAT2, CUTA, BCAT1 | LMNA 1260/4885DGKA 2902/4885CYP3A4 2195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.